Offrisk’s Business Continuity Plans for Biotechnology organisations encompass responses to risks from clinical and biological to reputational.

Our clients have used the plans to manage their approach to the successive foot and mouth crises and have plans covering the complex range of services to be recovered, taking full account of exacting hygiene requirements and the need to ensure valuable research can continue.